Item(by='lostcolony', descendants=None, kids=None, score=None, time=1605653951, title=None, item_type='comment', url=None, parent=25124364, text='So that assertion is only sorta true.<p>Initial discovery research is pretty much entirely tax payer funded. There&#x27;s then a second phase, moving from that discovery to POC, that is extremely underfunded, and which a lot of charity and such funding goes toward. It&#x27;s only the last phase, taking POCs -&gt; product, that companies really invest in. <a href="https:&#x2F;&#x2F;www.ncbi.nlm.nih.gov&#x2F;books&#x2F;NBK50972&#x2F;" rel="nofollow">https:&#x2F;&#x2F;www.ncbi.nlm.nih.gov&#x2F;books&#x2F;NBK50972&#x2F;</a><p>Now, that capital investment is not a trivial amount of money (about 80 billion in 2018 - <a href="https:&#x2F;&#x2F;www.statista.com&#x2F;statistics&#x2F;265085&#x2F;research-and-development-expenditure-us-pharmaceutical-industry&#x2F;" rel="nofollow">https:&#x2F;&#x2F;www.statista.com&#x2F;statistics&#x2F;265085&#x2F;research-and-deve...</a> ), but it still is only 17% of drug company revenues - <a href="https:&#x2F;&#x2F;www.investopedia.com&#x2F;ask&#x2F;answers&#x2F;060115&#x2F;how-much-drug-companys-spending-allocated-research-and-development-average.asp" rel="nofollow">https:&#x2F;&#x2F;www.investopedia.com&#x2F;ask&#x2F;answers&#x2F;060115&#x2F;how-much-dru...</a><p>Note, too, that private companies tend to fund research toward common first world diseases, since they&#x27;re profit driven, and far less to niche and&#x2F;or common third world diseases. So not only do they not fund early discovery (government does that), nor generally moving those discoveries to POCs (&#x27;valley of death&#x27;, and charitable foundations and the like do that), they also leave plenty of potential meds untouched, since the likely profitability is low.')